Clinical Trials Browser

Terminated × INDUSTRY × ofatumumab × Clear all

NCT01077518 2020-03-27

A+B

Phase 3 Terminated

346 enrolled 41 charts

Lymphoma, Follicular, Neoplasms

NCT01659021 2019-08-14

Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia

Phase 3 Terminated

261 enrolled 21 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01039376 2019-07-30

PROLONG

Phase 3 Terminated

480 enrolled 30 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT00748189 2019-06-25

COMPLEMENT 1

Phase 3 Terminated

447 enrolled 32 charts

LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01200589 2018-05-16

HOMER

Phase 3 Terminated

438 enrolled 14 charts

Lymphoma, Non-Hodgkin